Antibody-based therapies for COVID-19: Can Europe move faster?

por Kazatchkine, Michel D., Goldman, Michel, Vincent, Jean-Louis
Publicado 2020

Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?

por Bayry, Jagadeesh, Lacroix-Desmazes, Sébastien, Kazatchkine, Michel D, Kaveri, Srini V
Publicado 2004

“Rational Vaccine Design” for HIV Should Take into Account the Adaptive Potential of Polyreactive Antibodies

por Dimitrov, Jordan D., Kazatchkine, Michel D., Kaveri, Srinivas V., Lacroix-Desmazes, Sebastien
Publicado 2011

A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19

por Lung, Thomas, Kazatchkine, Michel D., Risch, Lorenz, Risch, Martin, Nydegger, Urs E.
Publicado 2020

Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide

por Carthagena, Laetitia, Becquart, Pierre, Hocini, Hakim, Kazatchkine, Michel D, Bouhlal, Hicham, Belec, Laurent
Publicado 2011

Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer

por Elluru, Sri Ramulu, van Huyen, Jean-Paul Duong, Delignat, Sandrine, Kazatchkine, Michel D, Friboulet, Alain, Kaveri, Srini V, Bayry, Jagadeesh
Publicado 2008

Affinity-Purified Respiratory Syncytial Virus Antibodies from Intravenous Immunoglobulin Exert Potent Antibody-Dependent Cellular Cytotoxicity

por Gupta, Nimesh, LeGoff, Jerome, Chamat, Soulaima, Mercier-Delarue, Severine, Touzelet, Olivier, Power, Ultan F., Kazatchkine, Michel D., Simon, Francois, Lacroix-Desmazes, Sebastien, Bayry, Jagadeesh, Kaveri, Srinivas V.
Publicado 2013